Nyumbani › Atrofi ya Misuli ya Utani
Majaribio ya kliniki ya Atrofi ya Misuli ya Utani yanayovutia washiriki nchini Marekani
Masomo 23 ya Atrofi ya Misuli ya Utani yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- New York City, NYUtafiti 9
- Mountain View, CAUtafiti 9
- Philadelphia, PAUtafiti 7
- Chicago, ILUtafiti 6
- Norfolk, VAUtafiti 6
- Grand Rapids, MIUtafiti 6
- Boston, MAUtafiti 5
- Houston, TXUtafiti 5
- Little Rock, ARUtafiti 4
- Lewisville, TXUtafiti 4
- Aurora, COUtafiti 4
- Phoenix, AZUtafiti 4
- Memphis, TNUtafiti 3
- Cedar Rapids, IAUtafiti 3
- Durham, NCUtafiti 3
- Columbia, MOUtafiti 3
- Orlando, FLUtafiti 3
- Minneapolis, MNUtafiti 3
- Charlottesville, VAUtafiti 3
- Portland, ORUtafiti 3
- Harrisburg, PAUtafiti 3
- Fort Worth, TXUtafiti 3
- Gainesville, FLUtafiti 3
- Dallas, TXUtafiti 3
- Atlanta, GAUtafiti 3
- Orange, CAUtafiti 3
Kwa jimbo
- ArizonaUtafiti 4
- ArkansasUtafiti 4
- CaliforniaUtafiti 11
- ColoradoUtafiti 4
- FloridaUtafiti 8
- GeorgiaUtafiti 3
- IllinoisUtafiti 6
- IowaUtafiti 3
- MassachusettsUtafiti 6
- MichiganUtafiti 6
- MinnesotaUtafiti 3
- MissouriUtafiti 4
- New YorkUtafiti 10
- North CarolinaUtafiti 3
- OregonUtafiti 3
- PennsylvaniaUtafiti 8
- TennesseeUtafiti 3
- TexasUtafiti 10
- VirginiaUtafiti 7
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
InaajiriHatua 4
3 Months – 24 Months · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT05861986A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
InaajiriHatua 2
Hadi umri 2 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07047144A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
InaajiriHatua 3
Umri 15 hadi 60 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07444476A Registry of Cases of Spinal Muscular Atrophy
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07805278ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
InaajiriHatua 4
Umri 2 hadi 100 · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT07448610A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
InaajiriHatua 2
Umri 5 hadi 17 · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07287982A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
InaajiriHatua 4
3 Months – 24 Months · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT05861999A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
InaajiriHatua 1
Umri 3 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT06555419Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
Inaajiri
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT07521930Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Inaajiri
Umri 3 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT05866419A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
InaajiriHatua 3
0 Days – 42 Days · Jinsia zote · Imesasishwa 18 Ago 2026 · NCT07221669A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
InaajiriHatua 3
0 Days – 7 Months · Jinsia zote · Imesasishwa 11 Ago 2026 · NCT07444450Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
InaajiriUtafiti wa uchunguzi
Umri 5 hadi 20 · Jinsia zote · Imesasishwa 9 Jul 2026 · NCT06532474Clinical Procedures to Support Research in ALS
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Jun 2026 · NCT03489278ALS/MND Natural History Study Data Repository
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 90 · Jinsia zote · Imesasishwa 20 Mei 2026 · NCT05966038Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA
InaajiriUtafiti wa uchunguzi
Umri 12 na zaidi · Jinsia zote · Imesasishwa 14 Mei 2026 · NCT06955897Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 5 na zaidi · Jinsia zote · Imesasishwa 9 Apr 2026 · NCT06839469HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
Inaajiri
Umri 5 hadi 17 · Jinsia zote · Imesasishwa 23 Mac 2026 · NCT07488338Gait and Bone Health in SMA
InaajiriUtafiti wa uchunguzi
Umri 8 hadi 50 · Jinsia zote · Imesasishwa 18 Mac 2026 · NCT07400198Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Mac 2026 · NCT07478172A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 54 · Wanawake · Imesasishwa 9 Mac 2026 · NCT05789758Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Jan 2026 · NCT07223489Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 31 Jan 2025 · NCT04174157Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.